-transparent.png){kind=logo}
Procainamide therapy has frequently been reported as a cause of agranulocytosis, but severe thrombocytopenia associated with the use of this drug has been noted only once. We report a case of simultaneously occurring agranulocytosis and profound thrombocytopenia in a patient receiving procainamide hydrochloride. Different mechanisms appeared to be responsible for the two cytopenias.
Related Publications
I K Rothman, and
E L Amorosi
June 1984,
Annals of internal medicine,
I K Rothman, and
E L Amorosi
January 1982,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
I K Rothman, and
E L Amorosi
December 1984,
Southern medical journal,
I K Rothman, and
E L Amorosi
February 1984,
American journal of hematology,
I K Rothman, and
E L Amorosi
February 1996,
Clinical immunology and immunopathology,
I K Rothman, and
E L Amorosi
January 1980,
Ugeskrift for laeger,
I K Rothman, and
E L Amorosi
November 1984,
Virginia medical,
I K Rothman, and
E L Amorosi
January 1984,
American journal of hematology,
I K Rothman, and
E L Amorosi
April 1984,
Annals of internal medicine,
I K Rothman, and
E L Amorosi
January 1980,
The Journal of the Kansas Medical Society,
